A patient preference study that evaluated fluticasone furoate and mometasone furoate nasal sprays for allergic rhinitis.

ABSTRACT:

Background

Corticosteroid nasal sprays are the mainstay of treatment for allergic rhinitis. These sprays have sensory attributes such as scent and/or odor, taste and aftertaste, and run down the throat and/or the nose, which, when unpleasant, can affect patient preference for, and compliance with, treatment.

Objective

This study examined patient preference for fluticasone furoate nasal spray (FFNS) or mometasone furoate nasal spray (MFNS) based on their sensory attributes after administration in patients with allergic rhinitis.

Methods

This was a multicenter, randomized, double-blind, cross-over study. Patient preferences were determined by using three questionnaires (Overall Preference, Immediate Attributes, and Delayed Attributes).

Results

Overall, 56% of pat

SUBMITTER: Yanez A 

PROVIDER: S-EPMC5244277 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature